Maladie du greffon contre l'hôte : Questions médicales fréquentes
Nom anglais: Graft vs Host Disease
Descriptor UI:D006086
Tree Number:C20.452
Termes MeSH sélectionnés :
Image Processing, Computer-Assisted
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Maladie du greffon contre l'hôte : Questions médicales les plus fréquentes",
"headline": "Maladie du greffon contre l'hôte : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Maladie du greffon contre l'hôte : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-17",
"dateModified": "2025-02-11",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Maladie du greffon contre l'hôte"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Maladies du système immunitaire",
"url": "https://questionsmedicales.fr/mesh/D007154",
"about": {
"@type": "MedicalCondition",
"name": "Maladies du système immunitaire",
"code": {
"@type": "MedicalCode",
"code": "D007154",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C20"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Syndrome de bronchiolite oblitérante",
"alternateName": "Bronchiolitis Obliterans Syndrome",
"url": "https://questionsmedicales.fr/mesh/D000092122",
"about": {
"@type": "MedicalCondition",
"name": "Syndrome de bronchiolite oblitérante",
"code": {
"@type": "MedicalCode",
"code": "D000092122",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C20.452.500"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Maladie du greffon contre l'hôte",
"alternateName": "Graft vs Host Disease",
"code": {
"@type": "MedicalCode",
"code": "D006086",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Stephanie J Lee",
"url": "https://questionsmedicales.fr/author/Stephanie%20J%20Lee",
"affiliation": {
"@type": "Organization",
"name": "Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington."
}
},
{
"@type": "Person",
"name": "Betty K Hamilton",
"url": "https://questionsmedicales.fr/author/Betty%20K%20Hamilton",
"affiliation": {
"@type": "Organization",
"name": "Blood and Marrow Transplant Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, United States of America."
}
},
{
"@type": "Person",
"name": "Najla El Jurdi",
"url": "https://questionsmedicales.fr/author/Najla%20El%20Jurdi",
"affiliation": {
"@type": "Organization",
"name": "Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, Minneapolis."
}
},
{
"@type": "Person",
"name": "Steven Z Pavletic",
"url": "https://questionsmedicales.fr/author/Steven%20Z%20Pavletic",
"affiliation": {
"@type": "Organization",
"name": "National Cancer Institute, Center for Cancer Research, National Institutes of Health, Bethesda, MD, United States of America."
}
},
{
"@type": "Person",
"name": "Anthony D Sung",
"url": "https://questionsmedicales.fr/author/Anthony%20D%20Sung",
"affiliation": {
"@type": "Organization",
"name": "Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Oral CT Image Processing Based on Oral CT Image Filtering Algorithm.",
"datePublished": "2022-09-19",
"url": "https://questionsmedicales.fr/article/36172316",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1155/2022/6041872"
}
},
{
"@type": "ScholarlyArticle",
"name": "Image Quality Improvement in Deep Learning Image Reconstruction of Head Computed Tomography Examination.",
"datePublished": "2023-08-09",
"url": "https://questionsmedicales.fr/article/37624111",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/tomography9040118"
}
},
{
"@type": "ScholarlyArticle",
"name": "Aneurysm growth evaluation and detection: a computer-assisted follow-up MRA analysis.",
"datePublished": "2024-08-23",
"url": "https://questionsmedicales.fr/article/39179696",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-024-70453-z"
}
},
{
"@type": "ScholarlyArticle",
"name": "Contemporary Advances in Computer-Assisted Bone Histomorphometry and Identification of Bone Cells in Culture.",
"datePublished": "2022-10-29",
"url": "https://questionsmedicales.fr/article/36309622",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00223-022-01035-2"
}
},
{
"@type": "ScholarlyArticle",
"name": "An unsupervised image registration method employing chest computed tomography images and deep neural networks.",
"datePublished": "2023-01-31",
"url": "https://questionsmedicales.fr/article/36738711",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.compbiomed.2023.106612"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies du système immunitaire",
"item": "https://questionsmedicales.fr/mesh/D007154"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladie du greffon contre l'hôte",
"item": "https://questionsmedicales.fr/mesh/D006086"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Maladie du greffon contre l'hôte - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Maladie du greffon contre l'hôte",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-04",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Maladie du greffon contre l'hôte",
"description": "Comment diagnostiquer la GVHD ?\nQuels tests sont utilisés pour la GVHD ?\nQuels signes cliniques indiquent la GVHD ?\nLa GVHD peut-elle être confondue avec d'autres maladies ?\nQuel rôle joue l'historique médical dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D006086?mesh_terms=Image+Processing,+Computer-Assisted&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Maladie du greffon contre l'hôte",
"description": "Quels sont les symptômes cutanés de la GVHD ?\nLa GVHD affecte-t-elle le système digestif ?\nQuels symptômes hépatiques sont associés à la GVHD ?\nLa GVHD peut-elle causer des problèmes oculaires ?\nQuels symptômes respiratoires peuvent survenir ?",
"url": "https://questionsmedicales.fr/mesh/D006086?mesh_terms=Image+Processing,+Computer-Assisted&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Maladie du greffon contre l'hôte",
"description": "Comment prévenir la GVHD après une greffe ?\nLe choix du donneur influence-t-il la GVHD ?\nLes traitements préventifs sont-ils efficaces ?\nLes greffes de cellules souches de sang de cordon sont-elles plus sûres ?\nLes soins post-greffe aident-ils à prévenir la GVHD ?",
"url": "https://questionsmedicales.fr/mesh/D006086?mesh_terms=Image+Processing,+Computer-Assisted&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Maladie du greffon contre l'hôte",
"description": "Quels traitements sont utilisés pour la GVHD ?\nLa photothérapie est-elle efficace contre la GVHD ?\nLes greffes de cellules souches peuvent-elles aider ?\nQuels médicaments sont prescrits pour la GVHD ?\nLa thérapie cellulaire est-elle une option ?",
"url": "https://questionsmedicales.fr/mesh/D006086?mesh_terms=Image+Processing,+Computer-Assisted&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Maladie du greffon contre l'hôte",
"description": "Quelles sont les complications de la GVHD ?\nLa GVHD peut-elle entraîner des infections ?\nQuels cancers peuvent survenir après la GVHD ?\nLa GVHD peut-elle affecter la qualité de vie ?\nComment gérer les complications de la GVHD ?",
"url": "https://questionsmedicales.fr/mesh/D006086?mesh_terms=Image+Processing,+Computer-Assisted&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Maladie du greffon contre l'hôte",
"description": "Quels sont les principaux facteurs de risque de la GVHD ?\nL'âge influence-t-il le risque de GVHD ?\nLe sexe du receveur joue-t-il un rôle ?\nLes antécédents médicaux augmentent-ils le risque ?\nLa source de greffe influence-t-elle le risque ?",
"url": "https://questionsmedicales.fr/mesh/D006086?mesh_terms=Image+Processing,+Computer-Assisted&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer la GVHD ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'examen clinique et des biopsies cutanées ou intestinales."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour la GVHD ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins et des biopsies sont effectués pour évaluer l'atteinte des organes."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent la GVHD ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent éruptions cutanées, diarrhée, et atteinte hépatique."
}
},
{
"@type": "Question",
"name": "La GVHD peut-elle être confondue avec d'autres maladies ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut être confondue avec des infections ou d'autres maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'historique médical dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'historique de greffe et les traitements antérieurs sont cruciaux pour le diagnostic."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes cutanés de la GVHD ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des éruptions, des démangeaisons et des desquamations."
}
},
{
"@type": "Question",
"name": "La GVHD affecte-t-elle le système digestif ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut provoquer des diarrhées, des douleurs abdominales et des nausées."
}
},
{
"@type": "Question",
"name": "Quels symptômes hépatiques sont associés à la GVHD ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent jaunisse, fatigue et élévation des enzymes hépatiques."
}
},
{
"@type": "Question",
"name": "La GVHD peut-elle causer des problèmes oculaires ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut entraîner sécheresse oculaire et inflammation conjonctivale."
}
},
{
"@type": "Question",
"name": "Quels symptômes respiratoires peuvent survenir ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme la toux, l'essoufflement et des infections pulmonaires peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Comment prévenir la GVHD après une greffe ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention inclut l'utilisation d'immunosuppresseurs et le choix de donneurs compatibles."
}
},
{
"@type": "Question",
"name": "Le choix du donneur influence-t-il la GVHD ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un donneur HLA compatible réduit le risque de GVHD."
}
},
{
"@type": "Question",
"name": "Les traitements préventifs sont-ils efficaces ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements préventifs diminuent significativement l'incidence de la GVHD."
}
},
{
"@type": "Question",
"name": "Les greffes de cellules souches de sang de cordon sont-elles plus sûres ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent présenter un risque réduit de GVHD par rapport aux greffes de moelle osseuse."
}
},
{
"@type": "Question",
"name": "Les soins post-greffe aident-ils à prévenir la GVHD ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un suivi médical rigoureux et des soins appropriés sont essentiels."
}
},
{
"@type": "Question",
"name": "Quels traitements sont utilisés pour la GVHD ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des corticostéroïdes et des immunosuppresseurs."
}
},
{
"@type": "Question",
"name": "La photothérapie est-elle efficace contre la GVHD ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la photothérapie peut être utilisée pour traiter les éruptions cutanées."
}
},
{
"@type": "Question",
"name": "Les greffes de cellules souches peuvent-elles aider ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des greffes supplémentaires peuvent être envisagées dans certains cas de GVHD sévère."
}
},
{
"@type": "Question",
"name": "Quels médicaments sont prescrits pour la GVHD ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments comme le méthotrexate et la ciclosporine sont souvent prescrits."
}
},
{
"@type": "Question",
"name": "La thérapie cellulaire est-elle une option ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la thérapie cellulaire peut être explorée pour des cas réfractaires."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications de la GVHD ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent infections, défaillance d'organes et cancers secondaires."
}
},
{
"@type": "Question",
"name": "La GVHD peut-elle entraîner des infections ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la GVHD affaiblit le système immunitaire, augmentant le risque d'infections."
}
},
{
"@type": "Question",
"name": "Quels cancers peuvent survenir après la GVHD ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des cancers comme le lymphome et le carcinome peuvent se développer après la GVHD."
}
},
{
"@type": "Question",
"name": "La GVHD peut-elle affecter la qualité de vie ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes et complications peuvent gravement impacter la qualité de vie."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications de la GVHD ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion inclut un suivi médical régulier et des traitements symptomatiques."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque de la GVHD ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge, le sexe, et la compatibilité HLA entre donneur et receveur."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque de GVHD ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les patients plus âgés ont un risque accru de développer la GVHD."
}
},
{
"@type": "Question",
"name": "Le sexe du receveur joue-t-il un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les hommes peuvent avoir un risque plus élevé de GVHD que les femmes."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux augmentent-ils le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de maladies auto-immunes ou de greffes augmentent le risque."
}
},
{
"@type": "Question",
"name": "La source de greffe influence-t-elle le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les greffes de moelle osseuse présentent un risque plus élevé que celles de sang de cordon."
}
}
]
}
]
}
The application of computer vision technology in the medical field provides more accurate technical support for oral disease detection. The research proposes the CT image denoising algorithm based on ...
In this study, we assess image quality in computed tomography scans reconstructed via DLIR (Deep Learning Image Reconstruction) and compare it with iterative reconstruction ASIR-V (Adaptive Statistica...
Growing intracranial aneurysms pose a high risk of rupture, making the detection and quantification of the growth crucial for timely treatment strategy adoption. In this paper we propose a computer-as...
Static and dynamic bone histomorphometry and identification of bone cells in culture are labor-intensive and highly repetitive tasks. Several computer-assisted methods have been proposed to ease these...
Deformable image registration is crucial for multiple radiation therapy applications. Fast registration of computed tomography (CT) lung images is challenging because of the large and nonlinear deform...
In this study, an unsupervised lung registration network (LRN) with cycle-consistent training is proposed to align two acquired CT-derived lung datasets during breath-holds at inspiratory and expirato...
The results showed that the LRN with an average TRE of 1.78 ± 1.56 mm outperformed VoxelMorph with an average TRE of 2.43 ± 2.43 mm, which is comparable to that of SSTVD with an average TRE of 1.66 ± ...
Therefore, this proposed method shows significant potential for use in time-sensitive pulmonary studies, such as lung motion tracking and image-guided surgery....
To perform a comprehensive intraindividual objective and subjective image quality evaluation of coronary CT angiography (CCTA) reconstructed with deep learning image reconstruction (DLIR) and to asses...
Fifty-one patients (29 males) undergoing clinically indicated CCTA from April to December 2021 were prospectively enrolled. Fourteen datasets were reconstructed for each patient: three DLIR strength l...
DLIR algorithm did not impact vascular attenuation (P ≥ 0.374). DLIR_H showed the lowest noise, comparable with ASiR-V 100% (P = 1) and significantly lower than other reconstructions (P ≤ 0.021). DLIR...
DLIR_M significantly improves CCTA image quality and has very strong correlation with routinely applied ASiR-V 50% dataset in the diagnosis of CAD....
Deep learning models achieve high-quality results in image processing. However, to robustly optimize parameters of deep neural networks, large annotated datasets are needed. Image annotation is often ...
Auxiliary diagnosis and monitoring of lung diseases based on lung ultrasound (LUS) images is important clinical research. A-line is one of the most common indicators of LUS that can offer support for ...
In order to solve the disadvantages of traditional A-line detection methods, realize automatic and accurate detection, and provide theoretical support for clinical application, we proposed a novel A-l...
First, the improved Faster R-CNN model with a selection strategy of localization box was designed to accurately locate the pleural line. Then, the LUS image below the pleural line was segmented for in...
After 100 epochs, the mean loss value of training and validation set of improved Faster R-CNN model reached 0.6540 and 0.7882, with the validation accuracy of 98.70%. The trained pleural line localiza...
The proposed method combining image processing and deep learning can automatically and accurately detect A-line in LUS images with different probe types, which has important application value for clin...
Image reconstruction from limited and/or sparse data is known to be an ill-posed problem and a priori information/constraints have played an important role in solving the problem. Early constrained im...
The identification of microalgae species is an important tool in scientific research and commercial application to prevent harmful algae blooms (HABs) and recognizing potential microalgae strains for ...